FDA Files Lawsuit Against Vape Junkie Ejuice for Unauthorized E-cigarette Sales

Regulations by 2FIRSTS.ai
Dec.05.2023
FDA Files Lawsuit Against Vape Junkie Ejuice for Unauthorized E-cigarette Sales
FDA files permanent injunction lawsuit against Vape Junkie Ejuice for unauthorized production and distribution of e-cigarette products.

According to a statement released by the US Food and Drug Administration (FDA) on December 4th, the FDA has filed a lawsuit through the US Department of Justice (DOJ) against e-cigarette liquid retailer Vape Junkie Ejuice, seeking a permanent injunction. The reason for the legal action is their production, sale, and distribution of unauthorized e-cigarette products.

FDA Files Lawsuit Against Vape Junkie Ejuice for Unauthorized E-cigarette Sales
Image source: 2FIRSTS

 

This case marks the FDA's seventh initiation of a ban enforcement procedure to carry out the pre-market review requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act) pertaining to novel tobacco products.

 

The FDA reports that despite issuing a warning to Vape Junkie Ejuice and threatening potential further actions, including a ban, the company continues to illicitly produce, sell, and distribute unauthorized e-cigarette products to consumers.

 

In response to this issue, Brian King, the Director of the Center for Tobacco Products (CTP) at the FDA, stated:

 

The FDA is very clear that we will not tolerate individuals openly disregarding the law, especially after being warned.

 

Currently, the Department of Justice (DOJ) has filed a lawsuit on behalf of the Food and Drug Administration (FDA), seeking an injunction against Vape Junkie Ejuice. The lawsuit demands that Vape Junkie Ejuice cease the production, sale, and distribution of their e-cigarette liquid and obtain market authorization from the FDA before selling such products.

 

Ann Simoneau, Director of Compliance and Enforcement Office at CTP, stated:

 

The ban action today should serve as a clear reminder to all manufacturers that if they continue to sell illegal products, we will fully leverage the power of the law. The FDA is committed to collaborating with federal partners, including the Department of Justice, to enforce the law.

 

The FDA has announced that it has taken action against manufacturers, distributors, importers, and retailers of illegal e-cigarette products over the past year. As of November 2023, the FDA has issued approximately 640 warning letters to companies involved in the production and/or distribution of illegal e-cigarette products and devices. In addition, over 400 warning letters have been sent to retailers selling unauthorized e-cigarettes, and civil penalty complaints have been filed against 36 e-cigarette manufacturers and 42 retailers for manufacturing and/or selling unauthorized products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) reported that from Sep 1 to Oct 12, 1,339 people were caught for vape-related offences, including 102 found in possession of etomidate-laced vapes.
Oct.17 by 2FIRSTS.ai
JT Launches Ploom AURA “Navy Blue” Edition with a Limited-Time Half-Price Offer
JT Launches Ploom AURA “Navy Blue” Edition with a Limited-Time Half-Price Offer
From Oct 14, JT will sell the Ploom AURA “Navy Blue” nationwide at convenience stores and select tobacco retailers; the starter kit will be ¥1,480 (down from ¥2,980) from Oct 13–Nov 9.
Oct.09
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
Japan Tobacco (JT) delivered a strong Q3 2025. Revenue rose 18.3% year over year to ¥947.2 billion, with adjusted operating profit up 27.8% to ¥279.0 billion (+20.8% at constant currency) and net profit up 29.7% to ¥176.7 billion. Growth was led by reduced-risk products (RRP): total RRP volume climbed 40%, with heated tobacco (HTS) up 53%. In Japan, the launches of Ploom AURA and EVO pods pushed HTS category share to 15.5%, while the Ploom user base has nearly doubled versus two years ago.
Oct.30 by 2FIRSTS.ai
Singapore rolls out red vape disposal bins: Ong Ye Kung says move protects youth and avoids criminal records
Singapore rolls out red vape disposal bins: Ong Ye Kung says move protects youth and avoids criminal records
Singapore Health Minister Ong Ye Kung explained that the islandwide rollout of red vape disposal bins is meant to let offenders—especially the roughly 30% of users under 30—surrender their devices without penalties, avoiding criminal records under the Misuse of Drugs Act. At the same time, the government has imposed tougher penalties on etomidate-laced “Kpods” (including mandatory minimum jail terms and caning) to choke off the supply chain. Authorities will review the effectiveness of the curre
Sep.08
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
BAT Japan to open two-storey glo™ Ginza flagship on Oct 18, 2025; sales + members’ lounge, promos; near IQOS.
Oct.11 by 2FIRSTS.ai